Approaches to managing patients with CIN in routine clinical practice
https://doi.org/10.21886/2219-8075-2020-11-4-92-98
Abstract
Objective: analyze the validity of destructive treatments for cervical diseases in clinical practice.
Materials and methods: analyzed archival medical documentation (medical records of an inpatient patient, form 003/y) of 258 patients who underwent surgical treatment of cervical diseases in 2017 – 2018. Statistical data were calculated on a personal computer using the Microsoft Excel 2011 for Mac program and the «Statistica» statistical program.
Results: an analysis of medical documentation revealed that a complete set of diagnostic methods, regulated by the clinical recommendations “Benign and precancerous cervical diseases from the perspective of cancer prevention” (2017), including HPV genotyping, was carried out in 28.7 % women. Before surgical treatment, a cytological examination of the cervix was carried out in 89.5 % cases, HPV-test — 31.4 % patients. As a result of the comparison of 258 histological and pre-operative clinical diagnoses, overdiagnosis of low- and high-grade cervical lesions (LSIL and HSIL) was noted in 16 (23.2 %) patients who did not have a history of childbirth and 42 (22.0 %) women who had previously given birth, which determined the use of destructive treatments without indications in 58 (22.5%) cases. An underestimation of the severity of cervical damage among unborn patients was found in 9 (13.0 %) patients, as well as in 40 (21.2 %) women with a history of childbirth.
Conclusions: overdiagnosis of the degree of intraepithelial cervical lesions entails the unreasonable use of destructive methods of treatment in young unborn women who violate the anatomic-functional integrity of the cervix and the architectonics of the cervical canal.
About the Authors
V. G. AnufrievaRussian Federation
Graduate student of the Department of obstetrics and gynecology №3,
Rostov-on-Don
E. Yu. Lebedenko
Russian Federation
Dr.Sci. (Med.), associate professor, professor of the Department of obstetrics and gynecology №3,
Rostov-on-Don
U. M. Magomedova
Russian Federation
Graduate student of the Department of obstetrics and gynecology №3,
Rostov-on-Don
A. F. Mikhelson
Russian Federation
Dr.Sci. (Med.), Professor, Honored Doctor of the Russian Federation head of the Department of obstetrics and gynecology №3,
Rostov-on-Don
References
1. Protasova A.E. Cervical Intraepithelial Neoplasia and Cervical Cancer. Is Human Papillomavirus the Only Risk. Effective pharmacotherapy. 2019; Vol. 15. №32: 42-46. (In Russ.) https://doi.org/10.33978/2307-3586-2019-15-32-42-46
2. N.M. Nazarova, V.N. Prilepskaya, K.I. Gusakov, E.G. Sycheva. HPV-Associated Diseases in Women and Men: Clinical and Practical Aspects. Meditsinskiy opponent=Medical opponent. 2018; 1(4): 22–28. (In Russ.) eLIBRARY ID: 36574688
3. Ashrafyan L.A. New drug strategy in the treatment of cervical neoplasias. Meditsinskiy opponent=Medical opponent 2019; 2(1): 10–16. (In Russ.) eLIBRARY ID: 36930681
4. Kyrgiou M, Mitra A, Arbyn M, Paraskevaidi M, Athanasiou A, Martin-Hirsch PPL, Bennett P, Paraskevaidis E. Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia. Cochrane Database of Systematic Reviews 2015, Issue 9. Art. No.: CD008478. https://doi.org/10.1002/14651858.CD008478.pub2
5. Kim M., Ishioka S., Endo T., Baba T., Saito T. Obstetrical prognosis of patients with cervical intraepithelial neoplasia (CIN) after «coin-shaped» conization // Arch. Gynecol. Obstet. 2016; Vol. 293 (3): 651-657. https://doi.org/10.1007/s00404-015-3860-5
6. Pokul L.V. Risk factors for cervical cancer // Journal of obstetrics and women's diseases. 2015; Т. 64; №6: 58-67. (In Russ.) https://doi.org/10.17816/JOWD64658-67
7. Levakov S.A., Kedrova A.G., Kozhurina E.V., Vanke N.S. Choice of treatment method for cervical dysplasia in women of reproducrive age. Effective pharmacotherapy. Obstetrics and gynecology. 2010; №3: 50-52. (In Russ.) LIBRARY ID: 21747175
8. Adams T.S., Mbatani N.H. Clinical management of women presenting with field effect of HPV and intraepithelial disease // Best Pract. Res. Clin. Obstet. Gynaecol. 2018; Vol. 47: 86-94. https://doi.org/10.1016/j.bpobgyn.2017.08.013
9. Liang Y., Chen M., Qin L., Wan B., Wang H. A meta-analysis of the relationship between vaginal microecology, human papillomavirus infection and cervical intraepithelial neoplasia // Infect. Agent. Cancer. 2019; Vol. 14: 29. https://doi.org/10.1186/s13027-019-0243-8
10. Yuldasheva D.Yu., Askarova U.J., Akhmedova G.A. Aggravating factors, contributing persistence of HPV in women with cervical interaepithelial neoplasia. Biology and integrative medicine. 2017; № 2: 55-63. (In Russ.) eLIBRARY ID: 28947771
Review
For citations:
Anufrieva V.G., Lebedenko E.Yu., Magomedova U.M., Mikhelson A.F. Approaches to managing patients with CIN in routine clinical practice. Medical Herald of the South of Russia. 2020;11(4):92-98. (In Russ.) https://doi.org/10.21886/2219-8075-2020-11-4-92-98